Acute Unstable Depressive Syndrome (AUDS) is associated more frequently with epilepsy than major depression

Arne E Vaaler, Gunnar Morken, Valentina C Iversen, Daniel Kondziella, Olav M Linaker, Arne E Vaaler, Gunnar Morken, Valentina C Iversen, Daniel Kondziella, Olav M Linaker

Abstract

Background: Depressive disorders are frequent in epilepsy and associated with reduced seizure control. Almost 50% of interictal depressive disorders have to be classified as atypical depressions according to DSM-4 criteria. Research has mainly focused on depressive symptoms in defined populations with epilepsy (e.g., patients admitted to tertiary epilepsy centers). We have chosen the opposite approach. We hypothesized that it is possible to define by clinical means a subgroup of psychiatric patients with higher than expected prevalence of epilepsy and seizures. We hypothesized further that these patients present with an Acute Unstable Depressive Syndrome (AUDS) that does not meet DSM-IV criteria of a Major Depressive Episode (MDE). In a previous publication we have documented that AUDS patients indeed have more often a history of epileptic seizures and abnormal EEG recordings than MDE patients (Vaaler et al. 2009). This study aimed to further classify the differences of depressive symptoms at admittance and follow-up of patients with AUDS and MDE.

Methods: 16 AUDS patients and 16 age- and sex-matched MDE patients were assessed using the Symptomatic Organic Mental Disorder Assessment Scale (SOMAS), the Montgomery and Asberg Depression Rating Scale (MADRS), and the Mini-Mental State Test (MMST), at day 2, day 4-6, day 14-16 and 3 months after admittance to a psychiatric emergency unit. Life events were assessed with The Social Readjustment Rating Scale (SRRS) and The Life Experience Survey (LES). We also screened for medication serum levels and illicit drug metabolites in urine.

Results: AUDS patients had significantly higher SOMAS scores (average score at admission 6.6 +/- 0.8), reflecting increased symptom fluctuation and motor agitation, and decreased insight and concern compared to MDE patients (2.9 +/- 0.7; p < 0.001). Degree of mood depression, cognition, life events, drug abuse and medication did not differ between the two groups.

Conclusions: AUDS patients present with rapidly fluctuating mood symptoms, motor agitation and relative lack of insight and concern. Seizures, epilepsy and EEG abnormalities are overrepresented in AUDS patients compared to MDE patients. We suggest that the study of AUDS patients may offer a new approach to better understanding epilepsy and its association with depressive disorders.

Trial registration: NCT00201474.

References

    1. Swinkels WA, Kuyk J, Van Dyck R, Spinhoven P. Psychiatric comorbidity in epilepsy. Epilepsy Behav. 2005;7(1):37–50. doi: 10.1016/j.yebeh.2005.04.012.
    1. Kanner AM. Depression and epilepsy: a new perspective on two closely related disorders. Epilepsy Curr. 2006;6(5):141–6. doi: 10.1111/j.1535-7511.2006.00125.x.
    1. Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry. 2003;54(3):388–98. doi: 10.1016/S0006-3223(03)00469-4.
    1. Boylan LS, Flint LA, Labovitz DL, Jackson SC, Starner K, Devinsky O. Depression but not seizure frequency predicts quality of life in treatment resistant epilepsy. Neurology. 2004;62(2):258–61.
    1. Giliam F, Hecimovic H, Sheline Y. Psychiatric comorbidity, health, and function in epilepsy. Epilepsy Behav. 2003;4(S):S26–30. doi: 10.1016/j.yebeh.2003.10.003.
    1. Pulsipher DT, Seidenberg M, Jones J, Hermann B. Quality of life and comorbid medical and psychiatric conditions in temporal lobe epilepsy. Epilepsy Behav. 2006;9(3):510–4. doi: 10.1016/j.yebeh.2006.07.014.
    1. Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007;75(2-3):192–6. doi: 10.1016/j.eplepsyres.2007.06.003.
    1. Kondziella D, Alvestad S, Vaaler A, Sonnewald U. Which clinical and experimental data link temporal lobe epilepsy with depression? J Neurochem. 2007;103(6):2136–52. doi: 10.1111/j.1471-4159.2007.04926.x.
    1. Cramer JA, Blum D, Reed M, Fanning K. The influence of comorbid depression on seizure severity. Epilepsia. 2003;44(12):1578–84. doi: 10.1111/j.0013-9580.2003.28403.x.
    1. Thapar A, Roland M, Harold G. Do depression symptoms predict seizure frequency - or vice versa? J Psychosom Res. 2005;59(5):269–74. doi: 10.1016/j.jpsychores.2005.04.001.
    1. Jones JE, Hermann BP, Barry JJ, Giliam FG, Kanner AM, Meador KJ. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav. 2003;4(S):S31–8. doi: 10.1016/j.yebeh.2003.08.019.
    1. Baker GA. Depression and suicide in adolescents with epilepsy. Neurology. 2006;66(S):S5–12.
    1. Pompili M, Girardi P, Tatarelli R. Death from suicide versus mortality from epilepsy in the epilepsies: a metaanalysis. Epilepsy Behav. 2006;9(4):641–8. doi: 10.1016/j.yebeh.2006.06.019.
    1. Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol. 2007;6(8):693–8. doi: 10.1016/S1474-4422(07)70175-8.
    1. Cramer JA, Blum D, Fanning K, Reed M. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav. 2004;5(3):337–42. doi: 10.1016/j.yebeh.2004.01.010.
    1. Yamamoto S, Miyamoto T, Morita N, Yasuda M. Depressive disorders preceding temporal lobe epilepsy. Epilepsy Res. 2002;49(2):153–6. doi: 10.1016/S0920-1211(02)00026-8.
    1. Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62(4):345–54. doi: 10.1016/j.biopsych.2006.09.023.
    1. Spencer S. Epilepsy: clinical observations and novel mechanisms. Lancet Neurol. 2007;6(1):14–6. doi: 10.1016/S1474-4422(06)70665-2.
    1. World Health Organization. 10th revision (ICD-10) Vol. 1. Geneva: WHO; 1992. International Statistical Classification of Diseases and Related Health Problems.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, DC: American Psychiatric Association; 2000.
    1. Krishnamoorthy ES, Trimble MR, Blumer D. The classification of neuropsychiatric disorders in epilepsy: A proposal by the ILAE Commission on psychobiology of epilepsy. Epilepsy Behav. 2007;10(3):349–53. doi: 10.1016/j.yebeh.2006.10.002.
    1. Seethalakshmi R, Krishnamoorthy ES. Depression in epilepsy: phenomenology, diagnosis and management. Epileptic Disord. 2007;9(1):1–10.
    1. Blumer D, Montouris G, Davies K. The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. Epilepsy Behav. 2004;5(6):826–40. doi: 10.1016/j.yebeh.2004.08.003.
    1. Mendez MF, Cumming J, Benson D. Depression in epilepsy: significance and phenomenology. Arch Neurol. 1986;43(8):444–l7.
    1. Vaaler AE, Morken G, Linaker OM, Sand T, Kvistad KA, Bråthen G. Symptoms of epilepsy and organic brain dysfunctions in patients with acute, brief depression combined with other fluctuating psychiatric symptoms: a controlled study from an acute psychiatric department. BMC Psychiatry. 2009;9:63. doi: 10.1186/1471-244X-9-63.
    1. Bjørk MH, Sand T, Bråthen G, Linaker OM, Morken G, Nilsen BM, Vaaler AE. Quantitative EEG findings in patients with acute, brief depression combined with other fluctuating psychiatric symptoms: a controlled study from the acute psychiatric department. BMC Psychiatry. 2008;8:89. doi: 10.1186/1471-244X-8-89.
    1. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Brit J Psychiatr. 1979;134(1):382–9. doi: 10.1192/bjp.134.4.382.
    1. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophren Bull. 1987;13(2):261–76.
    1. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975;12(3):189–98. doi: 10.1016/0022-3956(75)90026-6.
    1. O'Connor DW, Pollitt PA, Treasure FP, Brook CP, Reiss BB. The influence of education, social class and sex on Mini-Mental State scores. Psychol Med. 1989;19(3):771–6. doi: 10.1017/S0033291700024375.
    1. Holmes TH, Rahe RH. The Social Readjustment Rating Scale. J Psychosom Res. 1967;11(2):213–8. doi: 10.1016/0022-3999(67)90010-4.
    1. Sarason IG, Johnson JM, Siegel AG. Assessing the impact of life changes: Development of the life experiences survey. J Consult Clin Psychol. 1978;46(5):932–46. doi: 10.1037/0022-006X.46.5.932.
    1. Conigrave K, Hall W, Saunders J. The AUDIT questionnaire: Choosing a cut-off score. Alcohol Use Disorder Identification Test. Addiction. 1995;90(10):1349–56. doi: 10.1111/j.1360-0443.1995.tb03552.x.
    1. First MB, Spitzer RL, Gibbon M, Williams JB. Structured clinical interview for DSM-4 Axis 1 disorders-patient edition (SCID I/P, Version 2.0) Biometrics Research Department, New York State Psychiatric Institute, New York, NY; 1995.
    1. Krishnamoorthy ES. Treatment of depression in patients with epilepsy: problems, pitfalls, and some solutions. Epilepsy Behav. 2003;4(S3):46–54. doi: 10.1016/j.yebeh.2003.08.017.
    1. DeBattista C, Solomon A, Arnow B, Kendrick E, Tilston J, Schatzberg AF. The efficacy of divalproex sodium in the treatment of agitation associated with major depression. J Clin Psychopharmacol. 2005;25(5):476–9. doi: 10.1097/01.jcp.0000177552.21338.b0.
    1. Akiskal HS, Benazzi F, Perugi G, Rihmer Z. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: Implications for the antidepressant-suicide controversy. J Affect Disord. 2005;85(3):245–58. doi: 10.1016/j.jad.2004.12.004.
    1. Maj M, Pirozzi R, Magliano L, Fiorillo A, Bartoli L. Agitated "unipolar" major depression: prevalence, phenomenology, and outcome. J Clin Psychiatr. 2006;67(5):712–9. doi: 10.4088/JCP.v67n0504.
    1. Kondziella D, Asztely F. Don't be afraid to treat depression in patients with epilepsy! Acta Neurol Scand. 2009;119(2):75–80. doi: 10.1111/j.1600-0404.2008.01088.x.
    1. Kahn D, Stevenson E, Douglas CJ. Effect of sodium valproate in three patients with organic brain syndromes. Am J Psychiatry. 1988;145(8):1010–1.
    1. Harrow M, Hansford BG, Astrachan-Fletcher EB. Locus of control: Relation to schizophrenia, to recovery, and to depression and psychosis - A 15-year longitudinal study. Psychiatry Res. 2009;168(3):186–92. doi: 10.1016/j.psychres.2008.06.002.
    1. Rotter J. Internal versus external control of reinforcement: a case history of a variable. Am Psychologist. 1990;45(3):489–93. doi: 10.1037/0003-066X.45.4.489.
    1. Himmelhoch JD. In: Psychiatric aspects of epilepsy. Blumer D, editor. Washington, DC, American Psychiatric Press; 1984. Major mood disorders related to epileptic changes; pp. 271–94.
    1. Vaaler A, Morken G, Flovig JC, Iversen VC, Linaker OM. Substance abuse and recovery in a Psychiatric Intensive Care Unit. Gen Hosp Psychiatr. 2006;28(1):65–70. doi: 10.1016/j.genhosppsych.2005.08.009.
    1. Kanner AM. When did neurologists and psychiatrists stop talking to each other? Epilepsy Behav. 2003;4(6):597–601. doi: 10.1016/j.yebeh.2003.09.013.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj